Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Actuate Therapeutics, Inc.

NASDAQ: ACTU · Life Sciences · 4 alerts · CIK 1652935

Share price
$0.2680Close, Nov 16
Market cap
$16.2M
Shares outstanding
60.38MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Actuate Therapeutics, Inc. filings on SEC EDGAR ↗

4:05 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Actuate Therapeutics Nasdaq/NYSE Compliance Notice

Actuate Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 26, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. This notice follows a separate July 2026 warning regarding the company's failure to meet the minimum market value of listed securities requirement.

Counterparty
The Nasdaq Stock Market LLC
Term
180 days
5:17 PM ET 8-K
Capital Raise

Actuate Therapeutics Capital Raise of $11M

Actuate Therapeutics closed an underwritten public offering of 30,985,900 shares of common stock and warrants to purchase 15,492,950 shares, raising gross proceeds of approximately $11.0 million. The offering was priced at $0.71 per set of two shares and one warrant, implying a per-share price of $0.355. The company intends to use the net proceeds for working capital and general corporate purposes.

Value
$11M
Counterparty
Newbridge Securities Corporation

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.